Related Experiment Video
Updated: Jun 25, 2026
08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
[Long-term tococlysis with beta-2-mimetics--a retrospective analysis from one centre]
W Stein1, B Jahns, T Hawighorst
1Zentrum für Frauenheilkunde der Georg-August-Universität Göttingen. werner.stein@med.unigoettingen.de
Zeitschrift Fur Geburtshilfe Und Neonatologie
|March 5, 2009
Summary
Long-term tocolysis using beta-2-mimetics (Fenoterol) may improve outcomes for imminent preterm births. This study found reduced neonatal complications with increasing gestational age during tocolysis.
Area of Science:
- Perinatology
- Neonatology
- Pharmacology
Context:
- Current guidelines recommend limited tocolysis duration (<48 hours) except in select cases.
- Preterm birth remains a significant challenge in obstetrics and neonatology.
- Beta-2-mimetics like Fenoterol are commonly used tocolytic agents.
Purpose:
- To analyze the relevance and outcomes of long-term tocolysis with beta-2-mimetics (Fenoterol).
- To evaluate the impact of tocolysis duration on neonatal complications in relation to gestational age.
Summary:
- This study analyzed 69 cases of tocolysis, with 40.6% lasting longer than 7 days.
- Long-term tocolysis was frequently employed before 32 weeks gestation.
- Neonatal complications decreased significantly with advancing gestational age, particularly after 30 weeks.
Impact:
- Long-term tocolysis, especially before 32 weeks gestation, appears to be a viable therapeutic option.
- The findings suggest that the benefits of tocolysis increase with gestational age, improving preterm infant prognosis.
- This research supports considering extended tocolysis in cases of imminent preterm birth.
